whats MEY status, page-5

I personally think things are looking positive. The new processing technology they have doesn't seem risky to upscale. In this cost sensitive environment, any product that can cut a company's cost by up to 50% has to be appealing so acquiring clients should be just a matter of providing them with proof, which has already been done using smaller samples. Aligning with the CSIRO gives absolute credibility, so everyone is aware that the research rigor is impeccable. I also like the way directors bought their full entitlements in the last cap raising. I know only $15,000 but nobody likes to throw away money.
I'm hoping we will see an announcement before year end about the pilot plant. When that happens, the reality sets in that they really are doing what they claim.